Neuromyelitis optica (NMOSD): vizsgálatok itt: Törökország
1 trial · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- Kocaeli
- Életkor
- 2 év to 11 év
- People
- 8 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05199688 · EU 2023-507817-85-00